Author

N. Van Hoeven

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

E. Larson· 2 shared A. Gerhardt· 1 shared A. Khandhar· 1 shared B. Doranz· 1 shared B. Granger· 1 shared C. Casper· 1 shared C. Fox· 1 shared C. H. Linde· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

E. Larson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Thermostable, Flexible RNA Vaccine Delivery Platform for Pandemic Response

A. Gerhardt, E. Voigt, M. Archer, S. Reed, E. Larson, N. Van Hoeven, R. Kramer, C. Fox, C. Casper

This paper introduces a thermostable RNA vaccine delivery system stable at room temperature for 8+ months and refrigerated for 21+ months, improving vaccine distribution in low-resource settings.

bioRxiv · Feb 1, 2021Bioengineering

Integrated technology platform for accelerated discovery of antiviral antibody therapeutics

P. Gilchuk, R. G. Bombardi, J. H. Erasmus, Q. Tan, R. S. Nargi, C. Soto, P. Abbink, T. J. Suscovich, L. A. Dunellin, A. Khandhar, J. Archer, J. Liang, M. E. Fouch, E. Davidson, B. Doranz, , R. H. Carnahan

This study develops an integrated platform to rapidly discover and validate potent antiviral human monoclonal antibodies against Zika virus.

bioRxiv · May 12, 2020Immunology